Annovis Bio, Inc. (ANVS)
NYSE: ANVS · IEX Real-Time Price · USD
18.01
+4.41 (32.43%)
At close: Apr 26, 2024, 4:00 PM
17.90
-0.11 (-0.61%)
After-hours: Apr 26, 2024, 7:58 PM EDT
Annovis Bio Market Cap
Annovis Bio has a market cap or net worth of $198.31 million as of April 26, 2024. Its market cap has increased by 63.09% in one year.
Market Cap
198.31M
Enterprise Value
192.56M
1-Year Change
63.09%
Ranking
Category
Stock Price
$18.01
Market Cap Chart
Since January 29, 2020, Annovis Bio's market cap has increased from $56.80M to $198.31M, an increase of 249.14%. That is a compound annual growth rate of 34.29%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 25, 2024 | 139.60M | 6.81% |
Apr 24, 2024 | 130.70M | 7.22% |
Apr 23, 2024 | 121.90M | 3.39% |
Apr 22, 2024 | 117.90M | 14.24% |
Apr 19, 2024 | 103.20M | 2.08% |
Apr 18, 2024 | 101.10M | 9.53% |
Apr 17, 2024 | 92.30M | -10.74% |
Apr 16, 2024 | 103.40M | -9.14% |
Apr 15, 2024 | 113.80M | -4.69% |
Apr 12, 2024 | 119.40M | -4.63% |
Apr 11, 2024 | 125.20M | 3.81% |
Apr 10, 2024 | 120.60M | 2.29% |
Apr 9, 2024 | 117.90M | 0.26% |
Apr 8, 2024 | 117.60M | 3.25% |
Apr 5, 2024 | 113.90M | 0.53% |
Apr 4, 2024 | 113.30M | -2.24% |
Apr 3, 2024 | 115.90M | 1.05% |
Apr 2, 2024 | 114.70M | -6.52% |
Apr 1, 2024 | 122.70M | 0.49% |
Mar 28, 2024 | 122.10M | -1.13% |
Mar 27, 2024 | 123.50M | 2.15% |
Mar 26, 2024 | 120.90M | -0.98% |
Mar 25, 2024 | 122.10M | 5.17% |
Mar 22, 2024 | 116.10M | -4.37% |
Mar 21, 2024 | 121.40M | 6.58% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Regulus Therapeutics | 145.33M |
Biodesix | 144.33M |
Electromed | 143.97M |
ClearPoint Neuro | 143.51M |
Scilex Holding Company | 141.26M |
Repare Therapeutics | 139.20M |
Augmedix | 138.91M |
Syros Pharmaceuticals | 134.12M |